Kefir is a milk-derived product prepared by the incubation of kefir 'g
rains' with defatted milk. Various studies have been published on the
therapeutic effects of kefir. However, few controlled studies and litt
le information on the antibacterial, antifungal and antitumoural activ
ities of kefir have been published. Therefore, these activities associ
ated with kefir were investigated. The daily intraperitoneal administr
ation of 0.50 mL kefir for 20 days to mice; containing transplanted fu
siform cell carcomas resulted in a significant decrease in tumour size
. Kefir-induced disappearance of tumoural necrosis was also evident. W
ith respect to the antibacterial activity of kefir, the greatest activ
ity was exhibited against gram-positive coccus, staphylococcus, and gr
am-positive bacillus. Kefir 'grains' showed higher antibacterial activ
ity than kefir. Kefir also demonstrated antifungal activity against Ca
ndida, Saccharomyces, Rhodotorula, Torulopsis, Microsporum and Trichop
yton species. The results demonstrate that kefir possesses antibacteri
al, antifungal and antineoplastic activities, and provides credence to
the folklorec use of kefir for a variety of infectious and neoplastic
diseases.